Carnegie Investment Counsel’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,334
Closed -$291K 566
2025
Q4
$291K Sell
4,334
-654
-13% -$42.3K 0.01% 483
2025
Q3
$337K Sell
4,988
-619
-11% -$44.9K 0.01% 454
2025
Q2
$418K Buy
5,607
+164
+3% +$10.9K 0.01% 421
2025
Q1
$333K Buy
+5,443
New +$337K 0.01% 419
2021
Q2
Sell
-5,155
Closed -$240K 476
2021
Q1
$240K Buy
+5,155
New +$228K 0.01% 411
2020
Q1
Sell
-12,300
Closed -$364K 398
2019
Q4
$364K Sell
12,300
-8,516
-41% -$225K 0.02% 337
2019
Q3
$583K Buy
+20,816
New +$602K 0.04% 272

Other funds holding CTVA

Carnegie Investment Counsel's CTVA Position: Q1 2026 in Review

Carnegie Investment Counsel sold out of Corteva (CTVA) in Q1 2026, closing a stake of 4,334 shares — an estimated $291K sold.

Carnegie Investment Counsel first reported a position in CTVA in Q3 2019 and held it in 7 quarters. The position peaked at $583K in Q3 2019. 1,480 funds tracked by Wall St. Rank hold CTVA as of Q1 2026.

  • Carnegie Investment Counsel reported no remaining Corteva position as of Q1 2026 after selling out during the quarter.
  • Carnegie Investment Counsel sold 4,334 Corteva shares in Q1 2026, an estimated $291K.
  • Carnegie Investment Counsel first reported a position in Corteva in Q3 2019 and held it in 7 quarters.
  • Carnegie Investment Counsel's Corteva position peaked at $583K in Q3 2019.
  • 1,480 funds tracked by Wall St. Rank held Corteva as of Q1 2026.

Based on Carnegie Investment Counsel's 13F filing for Q1 2026, filed 1 May 2026.